HBOT After Cosmetic Surgery: Facelift, Tummy Tuck, and Laser Recovery Evidence

Plastic surgeons have used hyperbaric oxygen therapy (HBOT) for decades to rescue tissue that is dying after surgery, and that use is well supported. What is newer, and far less proven, is the idea that healthy cosmetic surgery patients should sit in an oxygen chamber to heal faster, bruise less, and get a better result. This article separates the strong evidence (salvaging compromised grafts and flaps) from the weak, early signals (routine recovery after a facelift, tummy tuck, or laser) so you can judge the marketing claims honestly.

What HBOT Actually Does to Healing Tissue

HBOT means breathing close to 100% oxygen inside a pressurized chamber, usually at 2.0 to 2.4 times normal atmospheric pressure (ATA). The pressure forces far more oxygen to dissolve directly into your blood plasma than you could ever carry on hemoglobin alone. That extra oxygen reaches tissue that has poor blood flow.

For wound healing, oxygen is not optional. It drives the work that surgical recovery depends on:

• Angiogenesis — growing new blood vessels into healing tissue.
• Fibroblast activity and collagen — the cells that lay down the scaffolding for repair need oxygen to build and cross-link collagen.
• Antimicrobial defense — white blood cells kill bacteria using oxygen-dependent reactions, so well-oxygenated wounds resist infection better.
• Reducing reperfusion injury — when blood flow returns to tissue that was briefly starved (as happens when a surgeon lifts a skin flap), HBOT may blunt the inflammatory damage.

These mechanisms are real and well-described. The honest question is not whether oxygen matters to healing. It is whether adding HBOT to an already-healthy patient changes the outcome enough to justify the time and cost. That is where the evidence gets thin.

A key distinction runs through this whole topic: poorly perfused tissue versus normally perfused tissue. When you lift a facelift skin flap or pull an abdominoplasty flap tight, the edge farthest from the blood supply is the most fragile — that is where necrosis and wound breakdown happen. HBOT's oxygen reaches that hypoxic edge, which is the entire theory behind using it in surgery. But on tissue that already gets plenty of oxygen through normal circulation, flooding the body with more does not obviously add anything. Your blood is already nearly saturated. This is why the strongest medical bodies endorse HBOT for failing tissue and stay silent or skeptical about routine use. The biology only clearly favors HBOT where blood flow is the bottleneck.

The Evidence Grades Are Not All Equal

A single sentence captures the whole field: HBOT for failing tissue is a recognized medical indication, while HBOT for routine cosmetic recovery is a hopeful idea backed mostly by small, weak studies. The table below grades each use the way a careful reader should.

Facelift Recovery: One Small Study, Big Headline Numbers

The most-cited study for facelifts is a 2023 case-control paper in Aesthetic Surgery Journal Open Forum. Patients who got HBOT (an average of about 7 sessions at 2.0 ATA) healed in roughly 13.3 days on average, versus 36.9 days in patients who did not. The difference was statistically significant (P < .001). On paper that looks dramatic.

Now read the fine print. The study included only 20 women total — 9 in the HBOT group and 11 controls — from a single surgical practice. It was retrospective. There was no blinding. The wound-healing assessments were subjective rather than measured against an objective standard, and one patient received only a single HBOT session. The authors themselves call for prospective, randomized, blinded trials before drawing conclusions.

A 20-person retrospective chart review cannot tell you that HBOT cut facelift healing time by more than half. It can only tell you that the question is worth a real trial. Treat the headline numbers as a hypothesis, not a fact.

Why the control group healed so slowly

One detail deserves scrutiny: the control group's 36.9-day average healing time is unusually long for an uncomplicated facelift. That hints the two groups may not have been comparable to begin with — perhaps sicker patients or worse healers were the ones offered HBOT, or the comparison captured a few outliers. When a control arm behaves oddly, the "treatment effect" can be an artifact of the groups not matching, not of the therapy working.

Tummy Tuck (Abdominoplasty): A Bigger but Still Imperfect Study

The abdominoplasty evidence is stronger than the facelift evidence, though it is still observational. A 2019 retrospective cohort in Plastic and Reconstructive Surgery Global Open looked at 356 women who had a tummy tuck; 83 received preoperative HBOT (1 to 3 sessions of 90 minutes at 2.0 ATA, the last the day before surgery). Postoperative complications fell from 32.6% in the no-HBOT group to 8.4% in the HBOT group (P < .001). After propensity-score matching, the gap held (6.3% vs. 39.7%), and HBOT came out as an independent protective factor.

Note what this study is and is not. It is preconditioning — oxygen loaded before surgery, not a recovery treatment afterward. And it is retrospective. The authors flag the obvious risk: the surgeons may have selected higher-risk patients (smokers, larger flaps) for HBOT, which would actually bias against HBOT, but selection bias can run in either direction. Necrosis, infection, and hypertrophic scarring occurred only in the control group, which is striking — but striking findings from non-randomized data are exactly the ones that most need a controlled trial to confirm.

A 2025 systematic review and meta-analysis in Aesthetic Plastic Surgery pooled 11 aesthetic-surgery studies (734 patients, 416 on HBOT) and reported shorter healing times overall, with a pooled average near 11 days. That sounds supportive, but the underlying studies are mostly the same retrospective and case-series designs described here. Pooling weak studies produces a more precise estimate of a possibly biased number. It does not create high-quality evidence.

This is the trap that makes HBOT marketing convincing. String together a flap-salvage meta-analysis, a tummy-tuck cohort, and a facelift chart review, and you can write a sentence like "multiple studies show HBOT improves surgical outcomes." Each statement is technically true. But the flap data are about dying tissue, the strongest cosmetic study is preconditioning before surgery, and the facelift data come from 20 people. None of it proves that a healthy patient recovering from elective surgery will heal meaningfully faster with HBOT. A separate 2025 systematic review focused on facial plastic and reconstructive surgery reached the predictable conclusion: the available studies are mostly low-level evidence, and rigorous prospective randomized trials are still needed before routine use can be recommended.

Laser Resurfacing: The Weakest Link

Aggressive ablative CO2 laser resurfacing leaves the face raw for days to weeks — a full-field treatment can mean 14 to 21 days before you look presentable. It is intuitive to think more oxygen would speed that up.

The data do not back the claim. A focused search turns up trials of topical oxygen emulsions, hyaluronic-acid dressings, and carboxytherapy masks after CO2 laser — but no published controlled trials of hyperbaric oxygen for laser recovery specifically. Clinics that advertise HBOT for laser downtime are extrapolating from facelift and flap data, not citing laser studies. That is a reasonable mechanistic guess, but it is not evidence. File it under "unproven."

There is also a mechanistic reason to doubt it. Laser resurfacing injures the skin from the surface down, leaving the deeper blood supply intact. The healing bottleneck after a laser is the epidermis re-growing over a raw surface, not a flap edge cut off from circulation. HBOT's strength is delivering oxygen to tissue that has lost its blood supply — which is not the main problem after most resurfacing. So even the theory is shakier here than it is for flaps. If a provider tells you HBOT will dramatically shorten laser downtime, ask them to show you a study. As of 2026, there isn't one to show.

Where the Evidence Is Genuinely Solid: Compromised Grafts and Flaps

The one cosmetic-adjacent use with real backing is salvaging tissue that is already failing. The Undersea and Hyperbaric Medical Society (UHMS) lists "compromised grafts and flaps" among its recognized indications for HBOT. This is supported by decades of animal models and clinical series.

A 2023 meta-analysis of randomized trials in skin-flap transplantation (13 RCTs, 1,226 patients) found HBOT significantly improved flap survival, with a large odds ratio. Reviews of compromised-flap salvage report survival rates roughly in the 62% to 97% range with HBOT versus 35% to 78% without — best when started within 72 hours. The timing matters: once tissue is fully dead, oxygen cannot revive it, so the window to act on a struggling flap is short. That urgency is part of why salvage is a real medical decision made by a surgeon, not a spa appointment you book in advance.

But even here, read carefully. Results are strongest for tissue that is compromised — irradiated, poorly perfused, or hypoxic. A landmark double-blind randomized trial by Bouachour (1996), in severe limb crush injuries, found that HBOT's benefit concentrated in the most severe cases (grade III injuries in patients over 40); it did not help every wound equally. And UHMS is blunt on the key point: HBOT is "neither necessary nor recommended for the support of normal, uncompromised grafts or flaps." In plain terms — if your tissue is healthy and healing normally, the strongest evidence in the whole field says you do not need a chamber.

Comparisons and Alternatives

Before booking sessions, weigh HBOT against cheaper, better-proven recovery steps. For most cosmetic patients, the basics move the needle more than oxygen does.

A typical "recovery package" of 5 to 10 HBOT sessions can run well over $2,000 out of pocket, and insurance will not cover cosmetic recovery. Compare that to the fact that not smoking costs nothing and prevents more complications than any chamber.

It is worth being specific about smoking because it is the clearest, most-proven lever. Nicotine constricts blood vessels and starves flap edges of exactly the oxygen HBOT is supposed to add. Surgeons routinely require patients to stop smoking for weeks before and after major flap surgery, and the reduction in necrosis and wound breakdown is well established. If you are spending money to improve healing, the order of operations is clear: stop nicotine, pick a skilled surgeon, follow aftercare instructions, manage your weight and blood sugar, and only then consider an unproven add-on like HBOT. Buying chamber sessions while still smoking is paying to push oxygen in through the front door while slamming the back door shut.

There is also an opportunity-cost angle. The hours spent driving to and sitting in a chamber across 5 to 10 sessions are hours not spent resting, which is itself a genuine part of recovery. For a low-risk cosmetic patient, the expected benefit is small and unproven while the cost in money, time, and minor side effects is certain.

Safety: Generally Low Risk, But Not Zero

HBOT is well tolerated, but it has real side effects. A 2023 systematic review and meta-analysis of 24 randomized trials (1,497 participants) found the HBOT groups had more adverse events overall than controls (about 30% vs. 10%). Most were minor and reversible.

• Ear barotrauma is the most common problem — pressure on the eardrum during compression. Reported in at least a couple percent of patients and often more; equalizing your ears (like on a plane) prevents most of it.
• Temporary nearsightedness (myopia) can appear after roughly 20 or more sessions as the lens of the eye swells. It almost always reverses after treatment ends. Most cosmetic recovery courses are far shorter than 20 sessions, so this is uncommon in this setting.
• Oxygen-induced seizures are rare and were not significantly more common than control in the meta-analysis, but they are the reason chambers are run by trained staff.
• Claustrophobia is real for some people inside an enclosed chamber.

Risk rises with higher pressure (above 2.0 ATA) and with longer courses (more than 10 sessions). Absolute contraindications include an untreated collapsed lung (pneumothorax) and certain chemotherapy drugs. Always disclose your full medication and medical history.

Who Might Reasonably Consider It

HBOT after cosmetic surgery makes the most sense for a narrow group:

• Patients whose surgeon sees a flap or graft starting to fail. This is the evidence-backed use. If your surgeon recommends HBOT to salvage compromised tissue, that is grounded in real data.
• Higher-risk patients facing a large flap procedure (for example, a tummy tuck in someone with risk factors), where preconditioning might help — understanding the evidence is one retrospective study.

For a healthy nonsmoker getting a routine facelift, laser, or standard tummy tuck, the honest answer is that HBOT is unproven for speeding recovery. It is not dangerous in most cases, but you would be paying for a hope, not a guarantee. Spend that money and energy on a skilled surgeon, quitting nicotine, and good aftercare first.

If you want to go deeper on the underlying science and economics, see our explainers on how hyperbaric oxygen therapy works, the HBOT wound-healing clinical evidence, HBOT for compromised skin grafts and flaps, HBOT for post-surgical recovery and healing, and what a single session actually costs in 2026.

Frequently Asked Questions

Does HBOT really cut facelift healing time in half?

That claim comes from a single 20-patient retrospective study where the HBOT group healed in about 13 days versus 37 days for controls. The numbers are real but the study is tiny, unblinded, and not randomized, and the control group healed unusually slowly. It is a hypothesis worth testing, not a proven result. Do not expect a guaranteed halving of your recovery.

Is HBOT after a tummy tuck worth the money?

The best evidence is one retrospective cohort of 356 patients where preoperative HBOT was linked to far fewer complications (8.4% vs. 32.6%). That is encouraging but unproven by a controlled trial, and it studied oxygen given before surgery, not as aftercare. If you are a higher-risk patient and your surgeon suggests it, it may be reasonable. For a routine, low-risk tummy tuck, the data do not justify the typical $2,000-plus cost.

Will HBOT speed up recovery after CO2 laser resurfacing?

There is no published controlled trial of hyperbaric oxygen specifically for laser recovery. Clinics that advertise it are extrapolating from facelift and flap data. Topical oxygen products and specialized dressings have actually been studied for laser downtime; hyperbaric oxygen has not. Treat HBOT-for-laser as unproven.

When does HBOT after cosmetic surgery actually have good evidence?

When tissue is failing. Salvaging a compromised (dying) skin graft or flap is a recognized UHMS indication backed by decades of data and meta-analyses showing improved flap survival, especially when started within 72 hours. The same societies are clear that healthy, normally healing tissue does not need HBOT.

Is HBOT safe after surgery?

For most people, yes, with mostly minor and reversible side effects. The most common is ear pressure (barotrauma); temporary nearsightedness can occur after about 20-plus sessions and reverses afterward. Serious events like oxygen seizures are rare and managed by trained staff. Risk rises at higher pressures and longer courses. Tell your provider about all medications and lung conditions first.

This article is for general information only and is not medical advice. Talk to your surgeon and a qualified hyperbaric physician before starting HBOT after any cosmetic procedure.

Sources

• Assessing the Efficacy of Hyperbaric Oxygen Therapy on Facelift Outcomes: A Case-Control Study (PMID 37529413)
• Hyperbaric Oxygen Preconditioning Can Reduce Postabdominoplasty Complications: A Retrospective Cohort Study (PMID 31772875)
• Effectiveness of Hyperbaric Oxygen Treatment in Facial Plastic and Reconstructive Surgery: A Systematic Review (PMID 38648530)
• Efficacy of Hyperbaric Oxygen Therapy as an Adjunct in Aesthetic Surgery: A Systematic Review and Meta-analysis (Aesthetic Plastic Surgery, 2025)
• Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled trial (PMID 8760546)
• UHMS Indications for Hyperbaric Oxygen Therapy (Compromised Grafts and Flaps)
• Hyperbaric Therapy for Skin Grafts and Flaps — StatPearls (NIH/NCBI Bookshelf)
• Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis (Frontiers in Medicine, 2023)
• PubMed search: hyperbaric oxygen therapy in aesthetic plastic surgery and wound healing